EGFR is a tyrosine kinase receptor that is often overexpressed or mutated in patients with non-small cell lung cancer (NSCLC), leading to uncontrolled cell proliferation and tumor formation (Riely et al., 2024). The gene discussed is NTRK1; the disease is non-small cell lung carcinoma.